CD34 and cancer: Similarly, ORP100S treatment attenuated induction of lipid peroxidation and intracellular ferrous iron by 5‐FU and cisplatin in EML cells and human CD34+ HSPCs, but had no effect in cancer cells (Figure 7F,G; Figure S13, Supporting Information).